Articles Tagged With: China
-
WHO International Emergency: A Great Wall Around China?
The World Health Organization (WHO) declared the 2019-nCoV outbreak in China a Public Health Emergency of International Concern (PHEIC) on Jan. 30, 2020. In doing so, WHO emphasized that China should not be isolated from the global community, which can happen after a PHEIC is issued.
-
Two U.S. Cases of Person-to-Person Transmission, More Expected
As of Feb. 13, 2020, there were 15 cases of the new coronavirus in the United States, with 13 of them infected travelers returning from Wuhan, China. There is concern that the community spread could continue, even as travel from China is being checked aggressively.
-
No Treatment, No Vaccine: Infection Preventionists Must Hold Line Against Emerging 2019-nCoV
Rigorous adherence to infection control measures is critical as a novel coronavirus (2019-nCoV) continues to emerge globally, threatening to transmit in the community and hospitals in the absence of an effective treatment or a vaccine, the Centers for Disease Control and Prevention emphasizes.
-
Pneumonia Outbreak in China
A cluster of cases of pneumonia apparently caused by a novel coronavirus has emerged in China.
-
Newly Recognized Rickettsial Infection in Eastern Central China
Fifty-six of 733 patients in China who were evaluated for suspected Severe Fever with Thrombocytopenia Syndrome (SFTS) were shown by polymerase chain reaction (PCR) to be infected with Candidatus Rickettsia tarasevichiae (CRT). Fever, myalgia, cough, gastrointestinal symptoms, and hemorrhagic manifestations were common. Rash was rarely seen, and eschar was observed in 16% of cases. Thrombocytopenia, leukopenia, and abnormal LFTs were commonly observed. Co-infection with SFTS virus was seen 66% of patients, and eight patients died.
-
FDA Notifications
The Food and Drug Administration (FDA) granted approval, on May 23, 2007, to a generic formulation of zidovudine capsules, 100 mg, manufactured by Cipla Limited, of Mumbai, India. -
AIDS Alert International: Study recommends monthly HIV tests for women in ART microbicide trials
The latest microbicide clinical trials will use antiretroviral therapy (ART), which holds both promise and more challenges for investigators.